Logo image of ADGM

ADAGIO MEDICAL HOLDINGS INC (ADGM) Stock Fundamental Analysis

NASDAQ:ADGM - Nasdaq - US00534B1008 - Common Stock - Currency: USD

1.4  -0.09 (-6.04%)

After market: 1.4799 +0.08 (+5.71%)

Fundamental Rating

1

ADGM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. ADGM has a bad profitability rating. Also its financial health evaluation is rather negative. ADGM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ADGM has reported negative net income.
ADGM had a negative operating cash flow in the past year.
ADGM Yearly Net Income VS EBIT VS OCF VS FCFADGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M -6M

1.2 Ratios

ADGM has a better Return On Assets (-6.83%) than 62.77% of its industry peers.
ADGM has a better Return On Equity (-11.32%) than 63.83% of its industry peers.
Industry RankSector Rank
ROA -6.83%
ROE -11.32%
ROIC N/A
ROA(3y)-2.97%
ROA(5y)N/A
ROE(3y)-4.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADGM Yearly ROA, ROE, ROICADGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -2 -4 -6 -8 -10

1.3 Margins

ADGM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADGM Yearly Profit, Operating, Gross MarginsADGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

ADGM has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ADGM has a worse debt to assets ratio.
ADGM Yearly Shares OutstandingADGM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
ADGM Yearly Total Debt VS Total AssetsADGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -0.41, we must say that ADGM is in the distress zone and has some risk of bankruptcy.
ADGM's Altman-Z score of -0.41 is in line compared to the rest of the industry. ADGM outperforms 43.62% of its industry peers.
ADGM has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
ADGM has a Debt to Equity ratio of 0.14. This is comparable to the rest of the industry: ADGM outperforms 55.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -0.41
ROIC/WACCN/A
WACCN/A
ADGM Yearly LT Debt VS Equity VS FCFADGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

ADGM has a Current Ratio of 0.01. This is a bad value and indicates that ADGM is not financially healthy enough and could expect problems in meeting its short term obligations.
ADGM has a Current ratio of 0.01. This is amonst the worse of the industry: ADGM underperforms 99.47% of its industry peers.
A Quick Ratio of 0.01 indicates that ADGM may have some problems paying its short term obligations.
ADGM has a Quick ratio of 0.01. This is amonst the worse of the industry: ADGM underperforms 99.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ADGM Yearly Current Assets VS Current LiabilitesADGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

ADGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -306.97%.
EPS 1Y (TTM)-306.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADGM Yearly Revenue VS EstimatesADGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
ADGM Yearly EPS VS EstimatesADGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ADGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADGM Price Earnings VS Forward Price EarningsADGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADGM Per share dataADGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ADGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADAGIO MEDICAL HOLDINGS INC

NASDAQ:ADGM (2/21/2025, 8:00:01 PM)

After market: 1.4799 +0.08 (+5.71%)

1.4

-0.09 (-6.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.37%
Inst Owner Change-9.91%
Ins Owners0.29%
Ins Owner Change-36.02%
Market Cap21.53M
AnalystsN/A
Price TargetN/A
Short Float %2.9%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS1.46
TBVpS1.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -11.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.97%
ROA(5y)N/A
ROE(3y)-4.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -0.41
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-306.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-263.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-155.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-163.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.47%
OCF growth 3YN/A
OCF growth 5YN/A